These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 5982985)

  • 21. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of brain amines in learning associated with "amphetamine-state".
    Roffman M; Lal H
    Psychopharmacologia; 1972; 25(3):195-204. PubMed ID: 4402958
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of imipramine on central monoamine neurons.
    Corrodi H; Fuxe K
    J Pharm Pharmacol; 1968 Mar; 20(3):230-1. PubMed ID: 4385053
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of alpha methyl-para-tyrosine on the recall of a passive avoidance response.
    Hall ME; Mayer MA
    Pharmacol Biochem Behav; 1975; 3(4):579-82. PubMed ID: 1187720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-methyltyrosine: effects on fixed ratio schedules of reinforcement.
    Schoenfeld R; Seiden LS
    J Pharm Pharmacol; 1967 Nov; 19(11):771-2. PubMed ID: 4383702
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of drugs on the behavioural and biochemical actions of intraventricular 6-hydroxydopamine.
    Taylor KM; Laverty R
    Eur J Pharmacol; 1972 Jan; 17(1):16-24. PubMed ID: 5016577
    [No Abstract]   [Full Text] [Related]  

  • 27. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiamphetamine effects following inhibition of tyrosine hydroxylase.
    Weissman A; Koe BK; Tenen SS
    J Pharmacol Exp Ther; 1966 Mar; 151(3):339-52. PubMed ID: 5938473
    [No Abstract]   [Full Text] [Related]  

  • 29. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
    Seiden LS; Martin TW
    Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
    Andén NE
    Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of benzquinamide on conditioned avoidance response and brain monoamine levels in the cat.
    Andén NE; Hanson L
    Psychopharmacologia; 1966; 10(2):110-5. PubMed ID: 6013801
    [No Abstract]   [Full Text] [Related]  

  • 32. Desynchronized sleep deprivation: learning deficit and its reversal by increased catecholamines.
    Hartmann E; Stern WC
    Physiol Behav; 1972 Apr; 8(4):585-7. PubMed ID: 5038128
    [No Abstract]   [Full Text] [Related]  

  • 33. Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline.
    Scheel-Krüger J; Randrup A
    Life Sci; 1967 Jul; 6(13):1389-98. PubMed ID: 6035768
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.
    Weissman A; Koe BK
    Life Sci; 1965 May; 4(10):1037-48. PubMed ID: 5838507
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
    Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
    [No Abstract]   [Full Text] [Related]  

  • 37. [Spontaneous movement and brain catecholamines in mice].
    Kameyama T; Kisara K
    Shinkei Kenkyu No Shimpo; 1966 Jul; 10(2):227-32. PubMed ID: 6010299
    [No Abstract]   [Full Text] [Related]  

  • 38. On the relation between motor activity and the degree of enzyme inhibition following inhibition of tyrosine hydroxylase.
    Svensson TH; Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1971; 29(1):60-4. PubMed ID: 4993687
    [No Abstract]   [Full Text] [Related]  

  • 39. Importance of noradrenaline found in a functional pool in maintaining spontaneous locomotor activity in rats.
    Chan OL; Webster RA
    Br J Pharmacol; 1971 Apr; 41(4):700-8. PubMed ID: 5579467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulus-dependent antagonism of the alpha-methyltyrosine-induced lowering of brain catecholamines by (+)-amphetamine in intact mice.
    Welch BL; Welch AS
    J Pharm Pharmacol; 1967 Dec; 19(12):841-3. PubMed ID: 4384230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.